Skip to main content

A TAILWIND FOR INDIAN PHARMA SECTOR

  ~ ANISH


The Indian pharma industry is on a good growth path and is likely to be in the top global markets in value term by 2020, according to the PwC – CII report titled “India Pharma industry ". 

India is called the pharmacy of the world. The drugs and pharmaceuticals sector have attracted cumulative FDI inflow . The Indian pharmaceuticals market has characteristics that make it unique. First,  branded generics dominate, making up for 70 to 80 per cent of the retail market.  Second, local players have enjoyed a dominant position driven by formulation  development capabilities . In addition to this, patent expiry or loss of brand exclusivity is also expected to result in higher exports of generic drugs. 



 Indian pharma companies are likely to focus on development of specialty medicines or complex generics to augment their portfolio and increase share in world exports. India has been newsworthy as a result of its indigenous phar- maceutical industry selling low-cost AIDS cocktails to South Africa in direct competition with drugs manufactured by multinationals.  70% of the pharmacetical market has been controlled by the leading 250 companies. The government has control over the price and there is severe price competition. 70% of the country’s demand has been met by the pharmaceutical industry.

We are at 11% of the generics market, if we accelerate the journey to at least 17% of the demand and given our exposure to exports, there is significant opportunity for us to drive the formulation business . Each industry in any country has its own strength . The growth of this industry is expected greatly because there is increase in potential. India's pharma sector products are cost effective and has good manufacturing power as compared to other countries . The marketing and supply chain is on the upper side in India . The manifold ecosystem also scale up the sector .



It is expected that the increase in export or generic drugs to the developed market will provide wide scope to perform large scale clinical trails for indian pharma sector .

Comments

Popular posts from this blog

Stagflation: A Threat to India

India is entering into the stage of stagflation, just 2 years ago it was expanding at 8% and emerging as a major global player, the situation has come down to this. With higher prices of food, The new citizenship act, and the central bank's target, India is meeting its slowest development in a decade. The inflation in December 2019 increased to 7.35 percent which was the highest since July 2014, which is past the RBI limit of 6%. But what led to this situation? We have had demonetization in 2016, the implementation of GST followed by many other policies but what led to this?  Let's look at some facts. The consumption of volatile oil makes up about 60% of gross domestic product which puts off all the investment plans. Economic growth in the fiscal year through March 31 is set to slow to an estimated 5%. Teresa John, an economist at Nirmal Bang Equities Pvt in Mumbai, quoted “The recovery is likely to be very gradual and a stagflation scenario is likely. ” The government has...

Changing Environment For Local Business In Sri Lanka; Government Initiates The Revolution

Local industries and businesses are the backbone of the economy of any country. Additionally, Sri Lankan Government defines a local company as one with a minimum ownership of 51% of a Sri Lankan. To help these companies grow, the Sri Lankan Finance Ministry has proclaimed a circular enlisting the priorities to the local companies. Moreover, this move from the government may bring some salient alterations in the condition of the local manufacturers. The government has also come with up steps that will augment the local industries across the different domains. These domains include IT sector, construction, etc. The circular, as issued by the government includes relevant documentation regarding sourcing of resources and products. Additionally, sources point towards the fact that the government is hoping to extend support to the domestic sector and help them grow. Besides, the major focus is on the three sectors- IT software and hardware, construction and furniture and allied products. Pos...

Significance of the “Developed Country” Tag for India

By Xeena Mehta The officials of the United States Trade Representative (USTR) uphold a list of countries that categorises countries as “developing”, “developed”, and “least-developed”. Countries that are classified as “developing” have permissions to export certain goods to the U.S. without being hit by heavy legal tariffs that are bind to be imposed on goods from “developed” countries. The “developing country” tag was originated by U.S. Trade Act of 1974, to aid poor countries develop faster. World Trade Organization also acceded to grant trade benefits to countries that were classified as poor. If noticed we can see that about two-thirds of countries that are members of the WTO classify themselves as “developing” countries and avail fore deals. Any such classification of whether a country is “developing” or not is entirely objective. While the economic progress achieved by India and China have achieved over the last few decades is seen as a valid reason to get rid of their s...